MEIP
|MEI Pharma Inc
NASDAQ
USD 2.24
+0.05|+2.28%
Current Price
USD 2.24
Change
+USD 0.05 (2.28%)
P/E Ratio
Dividend Yield
Market Cap
14.33M
Volume
1,700
Open
USD 2.16
Previous Close
USD 2.19
52-Week High
USD 4.10
52-Week Low
USD 1.46
About MEI Pharma Inc
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Justin J. File CPA
Employees:28
Headquarters:San Diego, USA
Website:meipharma.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|---|---|---|---|
| Nov 6, 2023 | Nov 17, 2023 | Dec 6, 2023 | USD 1.75 |
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions